BR112015022590B8 - Composição farmacêutica adequada para aplicação tópica à pele e/ou unhas, seu uso e método para melhorar a estabilidade de armazenamento de uma composição farmacêutica adequada para aplicação tópica à pele e/ou unhas - Google Patents
Composição farmacêutica adequada para aplicação tópica à pele e/ou unhas, seu uso e método para melhorar a estabilidade de armazenamento de uma composição farmacêutica adequada para aplicação tópica à pele e/ou unhasInfo
- Publication number
- BR112015022590B8 BR112015022590B8 BR112015022590A BR112015022590A BR112015022590B8 BR 112015022590 B8 BR112015022590 B8 BR 112015022590B8 BR 112015022590 A BR112015022590 A BR 112015022590A BR 112015022590 A BR112015022590 A BR 112015022590A BR 112015022590 B8 BR112015022590 B8 BR 112015022590B8
- Authority
- BR
- Brazil
- Prior art keywords
- topical application
- nails
- skin
- pharmaceutical composition
- composition suitable
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 6
- 230000000699 topical effect Effects 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 2
- 239000004202 carbamide Substances 0.000 abstract 2
- 150000002009 diols Chemical class 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 208000010195 Onychomycosis Diseases 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000026721 nail disease Diseases 0.000 abstract 1
- 201000005882 tinea unguium Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
COMPOSIÇÃO FARMACÊUTICA ADEQUADA PARA APLICAÇÃO TÓPICA À PELE E/OU UNHAS, SEU USO E MÉTODO PARA MELHORAR A ESTABILIDADE DE ARMAZENAMENTO DE UMA COMPOSIÇÃO FARMACÊUTICA ADEQUADA PARA APLICAÇÃO TÓPICA À PELE E/OU UNHAS. São fornecidas composições farmacêuticas adequadas para aplicação tópica para a unha para o tratamento de doenças da unha, tais como onicomicose, compreendendo um componente à base de ureia, um componente de diol, tal como propileno glicol, um componente de ácido orgânico, tal como ácido láctico, e um componente de triol, tal como glicerol. São fornecidos ainda métodos de melhorar a estabilidade de armazenamento de uma composição farmacêutica adequada para aplicação tópica à pele e/ou unhas que compreendem tais componentes à base de ureia, componentes de diol, componentes de ácidos orgânicos, e, opcionalmente, uma base aquosa, cujo método que compreende a adição de um componente de triol, tal como glicerol, para a composição antes do referido armazenamento.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2013/050654 WO2014140507A1 (en) | 2013-03-15 | 2013-03-15 | Pharmaceutical composition for the treatment of fungal infections |
| GBPCT/GB2013/050654 | 2013-03-15 | ||
| PCT/GB2014/050604 WO2014140524A1 (en) | 2013-03-15 | 2014-02-28 | Pharmaceutical composition for the treatment of fungal infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112015022590A2 BR112015022590A2 (pt) | 2017-07-18 |
| BR112015022590B1 BR112015022590B1 (pt) | 2020-08-25 |
| BR112015022590B8 true BR112015022590B8 (pt) | 2023-03-21 |
Family
ID=48142011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015022590A BR112015022590B8 (pt) | 2013-03-15 | 2014-02-28 | Composição farmacêutica adequada para aplicação tópica à pele e/ou unhas, seu uso e método para melhorar a estabilidade de armazenamento de uma composição farmacêutica adequada para aplicação tópica à pele e/ou unhas |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8987330B2 (pt) |
| EP (1) | EP2777689B1 (pt) |
| JP (1) | JP6503303B2 (pt) |
| KR (1) | KR101582448B1 (pt) |
| CN (2) | CN109394743A (pt) |
| BR (1) | BR112015022590B8 (pt) |
| CA (1) | CA2883613C (pt) |
| CY (1) | CY1116559T1 (pt) |
| DK (1) | DK2777689T3 (pt) |
| ES (1) | ES2543957T3 (pt) |
| HK (1) | HK1208378A1 (pt) |
| HR (1) | HRP20150823T1 (pt) |
| HU (1) | HUE026887T2 (pt) |
| IL (1) | IL241175B (pt) |
| ME (1) | ME02199B (pt) |
| MX (1) | MX2015012273A (pt) |
| MY (1) | MY176291A (pt) |
| PH (1) | PH12015502073B1 (pt) |
| PL (1) | PL2777689T3 (pt) |
| PT (1) | PT2777689E (pt) |
| RS (1) | RS54131B1 (pt) |
| SA (1) | SA515361162B1 (pt) |
| SG (1) | SG11201505763QA (pt) |
| SI (1) | SI2777689T1 (pt) |
| SM (1) | SMT201500214B (pt) |
| WO (2) | WO2014140507A1 (pt) |
| ZA (1) | ZA201505343B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014140507A1 (en) | 2013-03-15 | 2014-09-18 | Moberg Pharma Ab | Pharmaceutical composition for the treatment of fungal infections |
| KR101599260B1 (ko) * | 2015-07-30 | 2016-03-03 | (주)우신메딕스 | 조갑진균증의 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
| ITUB20153759A1 (it) * | 2015-09-21 | 2017-03-21 | Federica Livieri | Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo |
| US10251858B1 (en) | 2016-08-08 | 2019-04-09 | Marlinz Pharma, LLC | Composition for treating fungal infections in nails |
| US10543276B2 (en) | 2016-08-08 | 2020-01-28 | Marlinz Pharma, LLC | Topical compositions |
| GB2554101B (en) * | 2016-09-20 | 2021-05-05 | Insense Ltd | Composition for the treatment of a fungal infection |
| US20190151214A1 (en) * | 2017-11-21 | 2019-05-23 | Topix Pharmaceuticals, Inc. | Methods and compositions for treatment of skin |
| KR20210107043A (ko) * | 2018-12-19 | 2021-08-31 | 말린즈 파마 엘엘씨 | 국소 조성물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4296130A (en) | 1979-08-30 | 1981-10-20 | Herschler R J | Methylsulfonylmethane and methods of use |
| US4672078A (en) | 1985-07-03 | 1987-06-09 | Schering-Plough Corporation | Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations |
| US5525635A (en) | 1986-02-04 | 1996-06-11 | Moberg; Sven | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
| SE462139B (sv) * | 1986-02-04 | 1990-05-14 | Sven Moberg | Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem |
| US5696164A (en) * | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
| JP3820805B2 (ja) | 1999-07-08 | 2006-09-13 | 株式会社ノエビア | 皮膚外用剤 |
| JP2003095914A (ja) * | 2001-09-21 | 2003-04-03 | Toyo Beauty Kk | 尿素含有外用剤 |
| US6986896B2 (en) * | 2002-03-20 | 2006-01-17 | Bradley Pharmaceuticals, Inc. | Method of treating fungal conditions of the skin |
| US6573301B1 (en) * | 2002-04-23 | 2003-06-03 | Bradley Pharmaceuticals, Inc. | Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use |
| US8158138B1 (en) * | 2004-05-20 | 2012-04-17 | Fougera Pharmaceuticals, Inc. | Urea compositions and their methods of manufacture |
| JP4972895B2 (ja) * | 2005-08-29 | 2012-07-11 | 大正製薬株式会社 | 尿素配合外用製剤 |
| US8435500B2 (en) | 2005-11-01 | 2013-05-07 | L'oréal | Nail whitening composition |
| BR112012003209A2 (pt) | 2009-08-13 | 2016-03-01 | Moberg Derma Ab | composições e métodos para tratar infecção fúngica da unha |
| WO2012110430A1 (en) * | 2011-02-10 | 2012-08-23 | Moberg Derma Ab | Novel composition for topical use on a nail |
| WO2014140507A1 (en) | 2013-03-15 | 2014-09-18 | Moberg Pharma Ab | Pharmaceutical composition for the treatment of fungal infections |
-
2013
- 2013-03-15 WO PCT/GB2013/050654 patent/WO2014140507A1/en active Application Filing
-
2014
- 2014-02-28 EP EP14157373.3A patent/EP2777689B1/en active Active
- 2014-02-28 PL PL14157373T patent/PL2777689T3/pl unknown
- 2014-02-28 SG SG11201505763QA patent/SG11201505763QA/en unknown
- 2014-02-28 US US14/193,304 patent/US8987330B2/en active Active
- 2014-02-28 ES ES14157373.3T patent/ES2543957T3/es active Active
- 2014-02-28 KR KR1020157006206A patent/KR101582448B1/ko active IP Right Grant
- 2014-02-28 MX MX2015012273A patent/MX2015012273A/es active IP Right Grant
- 2014-02-28 CA CA2883613A patent/CA2883613C/en active Active
- 2014-02-28 PT PT141573733T patent/PT2777689E/pt unknown
- 2014-02-28 CN CN201811088339.6A patent/CN109394743A/zh active Pending
- 2014-02-28 HU HUE14157373A patent/HUE026887T2/en unknown
- 2014-02-28 CN CN201480002472.9A patent/CN104661639B/zh active Active
- 2014-02-28 DK DK14157373.3T patent/DK2777689T3/da active
- 2014-02-28 SI SI201430003T patent/SI2777689T1/sl unknown
- 2014-02-28 BR BR112015022590A patent/BR112015022590B8/pt active IP Right Grant
- 2014-02-28 WO PCT/GB2014/050604 patent/WO2014140524A1/en active Application Filing
- 2014-02-28 MY MYPI2015703030A patent/MY176291A/en unknown
- 2014-02-28 RS RS20150488A patent/RS54131B1/en unknown
- 2014-02-28 ME MEP-2015-112A patent/ME02199B/me unknown
- 2014-02-28 JP JP2015562293A patent/JP6503303B2/ja active Active
-
2015
- 2015-01-29 US US14/609,142 patent/US9782372B2/en active Active
- 2015-07-24 ZA ZA2015/05343A patent/ZA201505343B/en unknown
- 2015-07-28 HR HRP20150823TT patent/HRP20150823T1/hr unknown
- 2015-07-29 CY CY20151100666T patent/CY1116559T1/el unknown
- 2015-09-03 IL IL24117515A patent/IL241175B/en active IP Right Grant
- 2015-09-10 SM SM201500214T patent/SMT201500214B/xx unknown
- 2015-09-11 PH PH12015502073A patent/PH12015502073B1/en unknown
- 2015-09-15 SA SA515361162A patent/SA515361162B1/ar unknown
- 2015-09-18 HK HK15109199.3A patent/HK1208378A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015022590B8 (pt) | Composição farmacêutica adequada para aplicação tópica à pele e/ou unhas, seu uso e método para melhorar a estabilidade de armazenamento de uma composição farmacêutica adequada para aplicação tópica à pele e/ou unhas | |
| BR112015026023A2 (pt) | derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1 | |
| NI201600051A (es) | Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores | |
| EA201692334A1 (ru) | Кортикостероидные композиции для местного применения | |
| BR112016011065A8 (pt) | composto cristalino, composição farmacêutica, forma de dosagem, método para tratar anemia | |
| GT201700184A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| BR112017012504A2 (pt) | derivados de piperidina como inibidores de hdac1/2 | |
| SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
| CO7141430A2 (es) | Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación | |
| CO7131352A2 (es) | Composiciones farmacéuticas tópicas | |
| CL2013000866A1 (es) | Sales cristalinas oxalato y fosfato del conjugado naloxolpolietilenglicol; metodo de preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento del dolor. | |
| MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
| DOP2016000118A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
| BR112015026388A2 (pt) | métodos e composições para cicatrização de feridas | |
| DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
| MY193312A (en) | Topical formulation for promoting wound healing | |
| BR112018007068A2 (pt) | derivados de quinoxalina e piridopirazina como inibidores de pi3kbeta | |
| ECSP20023626A (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3 | |
| PH12018500910A1 (en) | Novel method of use and compositions | |
| BR112016029996A2 (pt) | utilização cosmética, composição e método cosmético para tratar os odores corporais | |
| BR112018012183A2 (pt) | composição cosmética e seu uso, formulação cosmética | |
| CR20150044A (es) | Formulación transdérmica que contiene inhibidores de cox | |
| BR112017009850A2 (pt) | composto, composição, e, uso de uma quantidade melhoradora de hiv de um composto | |
| ES2598753T3 (es) | Composición farmacéutica para el tratamiento de la tendinitis calcificada y/o bursitis calcificada | |
| BR112015014367A2 (pt) | formulações inibidoras de lfa-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/2014, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: MPJ OTC AB (SE) |
|
| B25D | Requested change of name of applicant approved |
Owner name: ADVANTICE HEALTH AB (SE) |